Congress trading

Every stock trade disclosed by Congress

Every line of every STOCK Act report we hold, from House Clerk and Senate recordsEvery STOCK Act trade since 2014. Newest filing first, as of Oct 31, 2026; narrow the record by member, party, chamber, ticker, account or size, and every name and ticker opens its own page.

10 NTLA trades by Democrats filed since 2014

Across 10 reports by 1 member · newest filing first · every Congress trade in the stock is on Intellia Therapeutics' page

Sizes are the dollar ranges members report, never an exact amount. How to read the cards.

Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.

  1. Donald S. Beyer, Jr.Democrat · House · VA
    Filed Mar 3, 2022one matching trade
    • sold NTLA Intellia Therapeutics Joint
      Traded Feb 28, 2022 · disclosed 3 days later
      $15,001 - $50,000
      Since the trade-86.6% since the saleEstimated exit price $98.85, close on Mon Feb 28, 2022Current price $13.23, close on Thu Oct 29
  2. Donald S. Beyer, Jr.Democrat · House · VA
    Filed Oct 30, 2021one matching trade
    • sold NTLA Intellia Therapeutics Joint
      Traded Oct 29, 2021 · disclosed 1 day later
      $1,001 - $15,000
      Since the trade-90.1% since the saleEstimated exit price $132.98, close on Fri Oct 29, 2021Current price $13.23, close on Thu Oct 29
  3. Donald S. Beyer, Jr.Democrat · House · VA
    Filed Oct 1, 2021one matching trade
    • sold NTLA Intellia Therapeutics Joint
      Traded Sep 20, 2021 · disclosed 11 days later
      $1,001 - $15,000
      Since the trade-91.1% since the saleEstimated exit price $148.36, close on Mon Sep 20, 2021Current price $13.23, close on Thu Oct 29
  4. Donald S. Beyer, Jr.Democrat · House · VA
    Filed Aug 7, 2021one matching trade
    • sold NTLA Intellia Therapeutics Joint
      Traded Jul 21, 2021 · disclosed 17 days later
      $1,001 - $15,000
      Since the trade-91.3% since the saleEstimated exit price $152.75, close on Wed Jul 21, 2021Current price $13.23, close on Thu Oct 29
  5. Donald S. Beyer, Jr.Democrat · House · VA
    Filed Jan 31, 2021one matching trade
    • sold NTLA Intellia Therapeutics Joint
      Traded Jan 15, 2021 · disclosed 16 days later
      $1,001 - $15,000
      Since the trade-83.8% since the saleEstimated exit price $81.89, close on Fri Jan 15, 2021Current price $13.23, close on Thu Oct 29
  6. Donald S. Beyer, Jr.Democrat · House · VA
    Filed Dec 1, 2020one matching trade
    • bought NTLA Intellia Therapeutics Joint
      Traded Nov 18, 2020 · disclosed 13 days later
      $1,001 - $15,000
      Since the trade-61.3% since the tradeEstimated entry price $34.23, close on Wed Nov 18, 2020Current price $13.23, close on Thu Oct 29
  7. Donald S. Beyer, Jr.Democrat · House · VA
    Filed Sep 6, 2020one matching trade
    • sold NTLA Intellia Therapeutics Joint
      Traded Aug 26, 2020 · disclosed 11 days later
      $1,001 - $15,000
      Since the trade-36.2% since the saleEstimated exit price $20.75, close on Wed Aug 26, 2020Current price $13.23, close on Thu Oct 29
  8. Donald S. Beyer, Jr.Democrat · House · VA
    Filed Aug 9, 2020one matching trade
    • bought NTLA Intellia Therapeutics Joint
      Traded Jul 10, 2020 · disclosed 30 days later
      $1,001 - $15,000
      Since the trade-44.4% since the tradeEstimated entry price $23.81, close on Fri Jul 10, 2020Current price $13.23, close on Thu Oct 29
  9. Donald S. Beyer, Jr.Democrat · House · VA
    Filed Feb 22, 2020one matching trade
    • bought NTLA Intellia Therapeutics Joint
      Traded Jan 14, 2020 · disclosed 39 days later
      $1,001 - $15,000
      Since the trade-8.9% since the tradeEstimated entry price $14.52, close on Tue Jan 14, 2020Current price $13.23, close on Thu Oct 29
  10. Donald S. Beyer, Jr.Democrat · House · VA
    Filed Dec 14, 2019one matching trade
    • bought NTLA Intellia Therapeutics Joint
      Traded Dec 9, 2019 · disclosed 5 days later
      $1,001 - $15,000
      Since the trade-20.9% since the tradeEstimated entry price $16.72, close on Mon Dec 9, 2019Current price $13.23, close on Thu Oct 29

How to read the cards

  • One card: one report a member filed with the House Clerk or the Secretary of the Senate, newest filing first, its trades in date order. A trade the report lists twice, on the same day in the same range for two accounts, shows once here.
  • Size: the dollar range on the report, never an exact figure. A value that is not one of the STOCK Act's ranges prints as listed, and "Not captured" means the range is missing from our data.
  • Traded and disclosed: the trade date, then the days until the member disclosed it. The STOCK Act allows 45 days. The date filter counts from the filing date, not the trade date.
  • Since the trade: each priced line shows the estimated entry or exit price and the current price it is worked out from. Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. An option line reads n/a, because an option's premium is never disclosed; so does any other line that is not a stock, and a stock line whose closing prices we do not hold or whose prices failed our checks. Not investment advice.
  • Filed late: only on reports we checked against the House Clerk's copy, listed on the late filings page. A checked card links the original.
  • Long reports: 20 reports to a page. A report longer than 60 trades is shortened here, and so are the reports after a page passes 250 trades; the member's own page has every trade.